alexa Utilization of Multiphoton Imaging For Real-Time Fate Determination of Mesenchymal Stem Cells in an Immunocompetent Mouse Model | OMICS International
ISSN: 2157-7633
Journal of Stem Cell Research & Therapy

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Utilization of Multiphoton Imaging For Real-Time Fate Determination of Mesenchymal Stem Cells in an Immunocompetent Mouse Model

Jay T Myers1, Agne Petrosiute1,2 and Alex Y Huang1,2*

1Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio 44106, USA

2Angie Fowler AYA Cancer Institute, University Hospitals Case Medical Center / Rainbow Babies & Children’s Hospital, Cleveland, Ohio 44106, USA

*Corresponding Author:
Alex Y Huang, M.D., Ph.D.
Department of Pediatrics, Case Western Reserve University
WRB 6528, 2103 Cornell Road, Cleveland, OH 44106-7288, USA
Tel: 1-216-368-1271
Fax: 1-216-844-5431
E-mail: [email protected]

Received date: June 20, 2014; Accepted date: July 17, 2014; Published date: July 19, 2014

Citation: Myers JT, Petrosiute A, Huang AY (2014) Utilization of Multiphoton Imaging For Real-Time Fate Determination of Mesenchymal Stem Cells in an Immunocompetent Mouse Model. J Stem Cell Res Ther 4:217. doi:10.4172/2157-7633.1000217

Copyright: © 2014 Myers JT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Stem Cell Research & Therapy


The clinical application of Mesenchymal Stem Cells (MSCs) for the treatment of a variety of diseases is the focus of intense research. Despite large research efforts many questions regarding MSC biology in vivo remain unanswered. For instance, we do not know for certain whether MSCs exert their therapeutic effects directly within the target tissue or indirectly by influencing the polarization of other cell types, such as macrophages, which can then home to the target tissue microenvironment. To help address this issue, the application of intravital multiphoton microscopy allows for the determination of the dynamic action of intact MSCs versus endogenous host cells at the target tissue site in real time.


Mesenchymal Stem Cell; MSC; Granulocyte; Multiphoton; Intravital; Mouse Model

Short Commentary

Over the past 10 years, the number of publications characterizing Mesenchymal Stem Cells (MSCs) has increased more than 10 fold (Figure 1) [1]. This is due to the realization of MSCs ability to home to sites of disease and tissue injury, as well as to modulate the actions of the immune system [2-16]. The plasticity of these cells and their ability to exhibit either a type 1 or type 2 response [17-19] has made them the focus of intense research for clinical purposes. Even with the increased interest in these cells, debate exists as to the fate of exogenously administered MSCs, including their mode of action and persistence in vivo [20,21]. Additional factors that complicate these determinations include the use of mouse [11,14,20] vs. human MSCs (hMSCs) [2,3,13,21], as well as the use of immunodeficient [2,3,12,13,16] vs. immunocompetent [9,15,21] mouse models when studying hMSCs. All of these caveats have led to reports of MSCs persisting in vivo for various durations from days [9,20] to weeks [15] after I.V. administration. Additionally, it has been shown that phagocytic granulocytes, composed largely of the monocyte/macrophage lineage, can take up and transport pieces of I.V. administered MSCs in immunocompetent mice [21]. Therefore it is possible that immunomodulatory effects seen upon MSC administration may be secondary to the effects of the MSCs on other host cells, which then home to sites of injury or disease [20]. The use of low resolution imaging modalities, including bioluminescence (BLI), PET and MRI, provides distribution data for administered MSCs in a global sense [8,9,15,22,23]. However, these inherently low-resolution imaging modalities do not address the dynamic intercellular interplay between MSCs and host immune cells, even in studies involving commonly employed immunocompromised mouse models that still contain abundant innate immune cells such as granulocytes which could be involved in the mechanism of action by MSCs in vivo [24-27]. Even as the number of MSC studies continues to grow exponentially, high-resolution in vivo imaging studies, especially dynamic intravital two-photon imaging studies, which are capable of addressing some of these questions in vivo, are lacking (Figure 1). It is therefore particularly important to devise a system to better determine the fate of these cells, their mode of action, and the role of other cells affected by MSCs. In order to address this issue, we’ve employed a fully immunocompetent mouse model developed by Thomas Graf [28]. In this mouse model, granulocytes are labeled by insertion of the Green Fluorescent Protein (GFP) into the Lysozyme M (LysM) locus. Additionally, it was shown that the differential expression levels of LysM by neutrophils (LysMhi) and monocytes (LysMlo) allow for the differentiation of these cells by their corresponding GFP expression. The administration of fluorescently labeled MSCs into these mice, in conjunction with high-resolution intravital multiphoton microscopy, now provides a platform for the direct determination of MSC’s homing potential to tissues such as the bone marrow. Furthermore, this imaging technique allows the differentiation between intact MSCs and granulocytes that have taken up cellular debris from the injected MSCs (Figure 2) [21]. Long-term tracking (minutes to hours) of the dynamic, individual interactions of these cells with any other cell type can provide cellular data that are far more relevant than in vitro tissue culture approaches or static imaging approaches via low-resolution imaging or high-definition histologic examination. For example, advances in the intravital multiphoton approach would allow scientists to determine if the accumulation of MSC signal seen in the tumor microenvironment is due to the direct homing of exogenously applied MSCs or to tissue macrophages which have taken up the MSC debris, and, in the process, may have been polarized functionally by the MSC to adopt a type 1 or type 2 immune response. Lastly, it should be possible to utilize highresolution intravital microscopy in conjunction with transgenic MSC cell lines expressing fluorescent proteins under the control of tissuespecific promoters, such as MyoD or Osterix for example, to determine the ultimate fate of these cells in vivo. These biological insights at the tissue level hold the key in further refining how MSCs can be used more effectively and efficiently in clinical applications.


Figure 1: Number of MSC related publications by year. Graph of the number of PubMed publications referencing “mesenchymal stem cell”, “mesenchymal stem cell imaging”, and “mesenchymal stem cell two-photon” by year from 1990 through 2013. The numbers at the end of each trend line represents the number of publications returned for 2013.


Figure 2: Two-photon imaging of fluorescently labeled MSCs in the bone marrow of a LysM+/GFP mouse. Real-time imaging of Cell Tracker Orange (CTO) labeled hMSCs in the bone marrow of a LysM+/GFP mouse 1 day after I.V. administration allows for the determination of intact MSCs (red arrows) versus MSCs phagocytosed by GFP+ granulocytes (yellow arrows). The paths of individual cells are tracked (white line). A. Combined GFP and CTO channels with representative pictures over a 10-min period. B. GFP-only channel. C. CTO only channel. D. CTO channel after subtraction of phagocytosed CTO signal. Note: Scale bars=20 μm.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 5th International Conference on Human Genetics and Genetic Disorders September 21-22,2018 Philadelphia, Pennsylvania, USA
    September 21-22,2018 Philadelphia, USA
  • 11th International Conference on Genomics and Pharmacogenomics September 21-22, 2018 Philadelphia, Pennsylvania, USA
    September 21-22, 2018 Philadelphia, USA
  • 5th World Congress on HUMAN GENETICS SEPTEMBER 24-25, 2018 BERLIN, GERMANY
    SEPTEMBER 24-25, 2018 Berlin, Germany
  • 21st Euro Biotechnology Congress October 11-12, 2018 Moscow, Russia
    October 11-12, 2018 Moscow, Russia
  • 11th International Conference on Tissue Engineering & Regenerative Medicine October 18-20, 2018 Rome, Italy
    October 18-20, 2018 Rome, Italy
  • 24th Biotechnology Congress: Research & Innovations October 24-25, 2018 Boston, USA
    October 24-25, 2018 Boston, USA
  • International Conference on Human Genome Meeting October 25-26, 2018 Istanbul, Turkey
    October 25-26, 2018 Istanbul, Turkey
  • International Congress & Expo on Genomics and Bioinformatics November 2-3, 2018 Columbus, Ohio, USA
    November 2-3, 2018 Columbus, USA
  • 12th International Conference & Exhibition on Tissue Preservation and Biobanking November 9-10, 2018 Atlanta, Georgia, USA
    November 9-10, 2018 Atlanta, USA
  • 2nd Annual Summit on Cell Therapy and Stem Cell Research November 9-10, 2018 Atlanta, Georgia, USA
    November 9-10, 2018 Atlanta, USA

Article Usage

  • Total views: 11934
  • [From(publication date):
    July-2014 - Sep 22, 2018]
  • Breakdown by view type
  • HTML page views : 8149
  • PDF downloads : 3785

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

bornova escort

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7